Cardiodynamics post Q2 increase
July 1, 2008
CardioDynamics International Corp., a leader of BioZ® Impedance Cardiography (ICG) technology, posted strong second quarter earnings based on an increase in sales and revenue.
This San Diego, Calif. company announced Tuesday that it earned $6.2 million, or $1.86 per diluted common share, in the second quarter ended May 31, an increase of 15 percent from $5.4 million, or 10 cents per diluted share, in the second quarter of 2007.
All About CARDIODYNAMICS INTL
Nasdaq: CDIC
CEO: Michael K. Perry
President: Rhonda F. Rhyne
Sector: Healthcare